Company intelligence / Profile preview

New Horizons Pharma

San Francisco, California, USAnhgpharma.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

New Horizons Pharma develops innovative IV-administered ALDH2 enzyme therapies targeting life-threatening conditions associated with ALDH2 deficiency. Their lead program addresses ischemia-reperfusion injury during myocardial infarction and several acute alcohol-related emergencies. The approach builds on foundational research showing that activating or supplementing ALDH2 can significantly reduce tissue damage post-injury. No published clinical results yet; programs are at an early development stage.

Therapeutic areas: OtherPsychiatryCardiovascularMetabolic Disorders
Modalities: Recombinant enzymes (ALDH2)Small molecules (Alda-1 activator referenced in research context)
Industry: Biotech

Drug pipeline

11 assets

DUEXIS

Commercial

Indications: Pain

10 more assets in the full pipeline.

Request access →

Partnerships

Academic collaboration with Stanford University cited as foundational for their scientific approach; no major pharma partnerships disclosed.

Beyond the preview

Go deeper on New Horizons Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Horizons Pharma.

Explore the full profile